Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models.

Joo-Eun LeeSe Yun JeongZijun LiHyun-Yi KimHyun-Woo KimMin Jeong YooHee Joo JangDo-Kyun KimNamki ChoHee Min YooKi Hyun Kim

Published in: Biomaterials research (2023)

This screening platform will open new paths by providing a promising standard system for discovering novel drug leads against SARS-CoV-2 and help develop promising candidates for clinical investigation as potential therapeutics for COVID-19.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
high throughput
small molecule
minimally invasive
human health
risk assessment
climate change